Nuventra Pharma Sciences is now Allucent. Learn more here.

Innovative solutions to
keep your project on course

Scientific Writing

Whether it is a clinical site interpreting a protocol, a peer reviewer deciding whether your manuscript should be accepted into a prestigious journal, or a regulatory agency reviewing your IND, it is important that your message is conveyed in a way that is clear, impactful, and appropriately written for your target audience.

Nuventra’s consultants bring many years of scientific, medical, and regulatory writing experience to meet our clients’ needs. Our consultants have experience authoring a diverse array of documents for submission to the FDA and other regulatory agencies, as well as scientific manuscripts for submission to peer-reviewed journals.

In addition to the experience of our consultants, Nuventra has critical infrastructure in place to ensure that the documents we deliver to our clients are of the highest caliber. We have robust document templates and medical writing SOPs coupled with a rigorous quality control (QC) process to allow for production of high quality, submission-ready documents.

Scientific Writing Services

Nuventra’s scientific writing team has the ability to handle any regulatory writing needs ranging from preparing full and complex applications (IND, NDA, BLA etc.) to smaller PK/PD, TK, population PK, or clinical study reports.

Contact us today to learn more about our scientific writing services. Our team will make sure that your documents are submission-ready.

Contact Us

Explore Our Blog

Pre-IND Meeting Guide: Benefits & How to Prepare

Regulatory guidelines allow for formal meetings between the FDA and sponsors or applicants to discuss the development and review of…

Read More

What Is CDISC and What Are CDISC Data Standards?

CDISC stands for the “Clinical Data Interchange Standards Consortium,” and is a global not-for-profit organization that actively develops data standards…

Read More

FDA Orphan Drug Designation for Rare Diseases

Content updated on April 21, 2021 An estimated 30 million people in the United States are afflicted with rare (orphan)…

Read More